慢性疾患管理：治療、デバイス技術、世界市場

Report Highlights

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Summary:

The global market for chronic disease management therapeutics and device technologies was $675.0 billion in 2023 and is expected to grow at a CAGR of 8.1%, reaching $1.1 trillion by the end of 2029. Growth of the global market is attributed to factors such as the increasing prevalence of chronic conditions, along with the adoption of personalized medicine and remote monitoring solutions.In this report, the market is segmented by product type, application, end user, and geography. Product  types include pharmaceutical drugs and biologics, medical devices, and digital therapeutics.

Pharmaceutical drugs and biologics are further segmented into drugs and biologics. Medical devices are further segmented into traditional devices and wearable devices. Applications include the following diseases: cancer, metabolic disorders, cardiovascular diseases, immunological disorders, respiratory diseases, musculoskeletal disorders, gastrointestinal disorders, neurological diseases and psychiatric disorders. The end-user market is segmented into home care, hospitals and others. The report also provides a regional market analysis of drug-device combinations.

Report Scope

Chronic disease management encompasses drugs and medical device-based techniques. This report can serve as an analytical business tool to evaluate the global market for therapeutics and advanced device technologies for chronic disease management.

This report analyzes market trends with data from 2023, estimates for 2024 and projections of CAGRs through 2029. It evaluates the market potential for chronic disease management and provides an analysis of the competitive landscape. The report covers the market’s drivers, restraints and opportunities, as well as the market shares of leading companies.

The market is segmented into product type, application, end user, and geographic region. Product segments include pharmaceuticals and biologics (drugs and biologics), medical devices (traditional and wearable devices) and digital therapeutics. Application areas (disease categories) are cancer, metabolic disorders, musculoskeletal disorders, cardiovascular conditions, immunological disorders, gastrointestinal disorders, respiratory diseases, neurological conditions, psychiatric conditions, and others. End users are categorized into hospitals and other facilities and home care. The global market is segmented into the regions of North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This analysis also includes broken down by country.

Report Synopsis

Report Includes

– 106 data tables and 39 additional tables

– Analyses of global market trends, with historic market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029

– Estimates of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application, end user, and region

– Analysis of the market dynamics, technological advances, regulations, and the macroeconomic factors influencing the market

– A look into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support chronic disease management

– Identification of promising new drugs, biologics, and emerging device technologies still in the development and testing stages

– A look at the regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products and their potential for commercialization

– A look at the recent patent grants

– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies

– Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook

– Profiles of market leaders, including Abbott, Bristol Myers Squibb Co., F. Hoffmann-La Roche Ltd., Pfizer Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

What’s New in This Update?

Market Summary

Chapter 2 Market Overview

Market Insights

Regulatory Background

Chronic Disease Management Act of 2021 (CDMA)

Regional Regulatory Frameworks for Chronic Disease Medical Devices

Regulatory Systems for Pharmaceuticals, by Region

Pricing and Reimbursement Background

Pricing and Reimbursement for Medical Devices, by Region

Pricing and Reimbursement for Pharmaceuticals, by Region

Chapter 3 Market Dynamics

Overview

Market Drivers

Growing Aging Population Worldwide

Growing Prevalence of Chronic Diseases

Technological Advances

Government Initiatives and Funding

Market Restraints

High Cost of Treatments

Patent Expiry and Shorter Product Life Cycles

Regulatory Issues for Drugs, Medical Devices and Software Applications

Limited Access in Low-Income Regions

Market Challenges

Medication Nonadherence

Regulatory Challenges

Challenges with Digital Health Applications

Market Opportunities

Digital Therapeutics

Strong Research and Development Initiatives from Key Market Players

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown

Market Analysis, by Product Type

Pharmaceutical Drugs and Biologics

Medical Devices

Digital Therapeutics

Market Analysis, by Application

Oncological Diseases

Metabolic Disorders

Cardiovascular Diseases

Immunological Disorders

Respiratory Diseases

Musculoskeletal Disorders

Chronic Gastrointestinal Diseases

Neurological Diseases

Psychiatric Disorders

Other Applications

Market Analysis, by End User

Home Care

Hospitals and Others

Geographic Breakdown

Market Analysis, by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 5 Emerging Trends and Technologies

Overview

Mobile Health Technology

AI, Machine Learning, and Deep Learning in Chronic Care Management

Remote Patient Monitoring Devices

Digital Therapeutics

Biowearable Technology

Glucose-Sensing Contact Lenses

Recent Approvals and Launches of Novel Drug and Device Products

Chapter 6 ESG Developments

ESG in the Chronic Disease Management Industry

ESG Risk Ratings

BCC Research Viewpoint

Chapter 7 Competitive Landscape

Mergers, Acquisitions and Collaborations

Patent Analysis

Patent Review, by Assignee Country

Patent Review, by Year

Company Share Analysis

Strategic Alliances

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

ABBOTT

AMGEN INC.

ASTRAZENECA

BOSTON SCIENTIFIC CORP.

BRISTOL-MYERS SQUIBB CO.

1. HOFFMANN-LA ROCHE LTD.

GSK PLC.

JOHNSON & JOHNSON SERVICES INC.

MEDTRONIC

PFIZER INC.

List of Tables

Summary Table : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, Through 2029

Table 1 : People 65 Years and Over, by Development Group, 2023 and 2050

Table 2 : People 65 Years or Over, by WHO Region, 2019 and 2050

Table 3 : Projected Number of U.S. Adults 50 and Older with More than One Chronic Condition

Table 4 : Recent EU-Level Initiatives Addressing Chronic Diseases, 2022

Table 5 : Weighted Adherence Rates in India, 2022

Table 6 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, Through 2029

Table 7 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Disease Management, by Region, Through 2029

Table 8 : Global Market for Pharmaceutical Drugs and Biologics for Chronic Diseases Management, by Product, Through 2029

Table 9 : Recently Approved Pharmaceutical Drugs for Chronic Disease Management, 2024

Table 10 : Global Market for Pharmaceutical Drugs in Chronic Disease Management, by Region, Through 2029

Table 11 : Recently Approved Biologics for Chronic Disease Management, 2024

Table 12 : Global Market for Biologics in Chronic Disease Management, by Region, Through 2029

Table 13 : Global Market for Medical Devices for Chronic Disease Management, by Region, Through 2029

Table 14 : Global Market for Medical Devices for Chronic Disease Management, by Product Type, Through 2029

Table 15 : Global Market for Traditional Medical Devices for Chronic Disease Management, by Region, Through 2029

Table 16 : Global Market for Wearable Medical Devices for Chronic Disease Management, by Region, Through 2029

Table 17 : Global Market for Digital Therapeutics for Chronic Disease Management, by Region, Through 2029

Table 18 : Global Market for Therapeutics and Device Technologies for Chronic Disease Management, by Application, Through 2029

Table 19 : Cancer Deaths in the U.S., 2024

Table 20 : Global Market for Oncology Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 21 : Global Market for Metabolic Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 22 : Global Market for Cardiovascular Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 23 : Global Market for Immunological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 24 : Global Market for Respiratory Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 25 : Global and Regional Key Findings on Rehabilitation Needs, 2021

Table 26 : Global Market for Musculoskeletal Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 27 : Global Market for GI Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 28 : Global Market for Neurological Disorder Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 29 : Global Market for Psychiatric Diseases Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 30 : Global Market for Other Disease Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 31 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 32 : Global Market for Home Care Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 33 : Global Market for Therapeutics and Device Technologies in Hospitals and Other Facilities in Chronic Disease Management, by Region, Through 2029

Table 34 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, Through 2029

Table 35 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 36 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 37 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 38 : North American Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029

Table 39 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 40 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 41 : U.S. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 42 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 43 : Canada Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 44 : Canadian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 45 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 46 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 47 : Mexican Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 48 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 49 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 50 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 51 : European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029

Table 52 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 53 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 54 : U.K. Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 55 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 56 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 57 : French Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 58 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 59 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 60 : Italian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 61 : Leading Causes of Disease Burden in Germany, by DALYs (Level 3), 2022

Table 62 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 63 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 64 : German Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 65 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 66 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 67 : Spanish Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 68 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 69 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 70 : Rest of European Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 71 : Percentage of Healthcare Professionals who Use Digital Health Technology or Mobile Health Apps, by Country, 2021

Table 72 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 73 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 74 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 75 : Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Country, Through 2029

Table 76 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 77 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 78 : Chinese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 79 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 80 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 81 : Indian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 82 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 83 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 84 : Japanese Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 85 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 86 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 87 : Australian Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 88 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 89 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 90 : South Korean Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 91 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product, Through 2029

Table 92 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 93 : Rest of Asia-Pacific Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 94 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Product Through 2029

Table 95 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by Application, Through 2029

Table 96 : RoW Market for Therapeutics and Device Technologies in Chronic Disease Management, by End User, Through 2029

Table 97 : AI-driven Drug Discovery and Development in Cardiology

Table 98 : ESG Highlights, by Leading Companies, 2023

Table 99 : ESG Risk Ratings for Pharma Firms in the Chronic Disease Management Market, 2023

Table 100 : M&A in the Chronic Disease Management Industry, 2021–2024

Table 101 : Patent Analysis, by Year, 2021–August 2024

Table 102 : Strategic Alliances in the Chronic Disease Management, Therapeutics and Device Technologies Market, 2021–2024

Table 103 : Information Sources in This Report

Table 104 : Abbreviations Used in This Report

Table 105 : Abbott: Company Snapshot

Table 106 : Abbott: Financial Performance, FY 2022 and 2023

Table 107 : Abbott: Product Portfolio

Table 108 : Abbott: News/Key Developments, 2023 and 2024

Table 109 : Amgen Inc.: Company Snapshot

Table 110 : Amgen Inc.: Financial Performance, FY 2022 and 2023

Table 111 : Amgen Inc.: Product Portfolio

Table 112 : Amgen Inc.: News/Key Developments, 2021–2024

Table 113 : AstraZeneca: Company Snapshot

Table 114 : AstraZeneca: Financial Performance, FY 2022 and 2023

Table 115 : AstraZeneca: Product Portfolio

Table 116 : AstraZeneca: News/Key Developments, 2021–2024

Table 117 : Boston Scientific Corp.: Company Snapshot

Table 118 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023

Table 119 : Boston Scientific Corp.: Products Portfolio

Table 120 : Boston Scientific Corp.: News/Key Developments, 2023 and 2024

Table 121 : Bristol-Myers Squibb Co.: Company Snapshot

Table 122 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023

Table 123 : Bristol-Myers Squibb Co.: Product Portfolio

Table 124 : Bristol-Myers Squibb Co.: News/Key Developments, 2021–2024

Table 125 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 126 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 127 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 128 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2021–2024

Table 129 : GSK Plc.: Company Snapshot

Table 130 : GSK Plc.: Financial Performance, FY 2022 and 2023

Table 131 : GSK Plc.: Product Portfolio

Table 132 : GSK Plc.: News/Key Developments, 2024

Table 133 : Johnson & Johnson Services Inc.: Company Snapshot

Table 134 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023

Table 135 : Johnson & Johnson Services Inc.: Product Portfolio

Table 136 : Johnson & Johnson Services Inc.: News/Key Developments, 2022–2024

Table 137 : Medtronic: Company Snapshot

Table 138 : Medtronic: Financial Performance, FY 2022 and 2023

Table 139 : Medtronic: Product Portfolio

Table 140 : Medtronic: News/Key Developments, 2022–2024

Table 141 : Pfizer Inc.: Company Snapshot

Table 142 : Pfizer Inc.: Financial Performance, FY 2022 and 2023

Table 143 : Pfizer Inc.: Product Portfolio

Table 144 : Pfizer Inc.: News/Key Developments, 2022–2024

List of Figures

Summary Figure : Global Market for Chronic Disease Management, Therapeutics and Device Technologies, by Product Type, 2021–2029

Figure 1 : Use of Digital Technologies and Data in Patients’ Medicines

Figure 2 : Comparison of Drug Approval Processes in the U.S. and EU

Figure 3 : Market Dynamics for Therapeutics and Devices for Chronic Disease Management

Figure 4 : Share of New Global Cases of Cancer, by Region, 2022

Figure 5 : Share of Global Cancer Mortality Cases, by Region, 2022

Figure 6 : Frequency of Non-adherence Behaviors, 2020

Figure 7 : Global Market Share of Therapeutics and Device Technologies for Chronic Disease Management, by Product Type, 2023

Figure 8 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by End User, 2023

Figure 9 : Global Market for Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2021–2029

Figure 10 : Global Market Share of Therapeutics and Device Technologies in Chronic Disease Management, by Region, 2023

Figure 11 : Role of AI in Anti-Cancer Drug Development

Figure 12 : 2024 Progress Assessment: Tracking Sustainable Development Goals

Figure 13 : Share of Patents Published on Chronic Disease Management, by Assignee Country, 2021–2024

Figure 14 : Global Market Shares of Chronic Disease Management, Therapeutics and Device Technologies, by Leading Companies, 2023

Figure 15 : Abbott: Revenue Share, by Country/Region, FY 2023

Figure 16 : Abbott: Revenue Share, by Business Unit, FY 2023

Figure 17 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023

Figure 18 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023

Figure 19 : AstraZeneca: Revenue Share, by Country/Region, FY 2023

Figure 20 : AstraZeneca: Revenue Share, by Business Unit, FY 2023

Figure 21 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023

Figure 22 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023

Figure 23 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023

Figure 24 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023

Figure 25 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 26 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 27 : GSK Plc.: Revenue Share, by Country/Region, FY 2023

Figure 28 : GSK Plc.: Revenue Share, by Business Unit, FY 2023

Figure 29 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023

Figure 30 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023

Figure 31 : Medtronic: Revenue Share, by Country/Region, FY 2023

Figure 32 : Medtronic: Revenue Share, by Business Unit, FY 2023

Figure 33 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023

Figure 34 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧